Saturday 24 December 2016

World of Medicine Research - Interesting Reads


The Upside of a little butter: Meta-analysis of 9 studies from 15 countries found that a modest daily amount of butter was associated with a four percent decrease in Diabetes risk. The same amount of butter does not seem to increase the risk of cardiovascular disease and stroke. Moderation is a good strategy when it comes to hgh fat food such as butter. 

Antioxidants don't work. Well i have seen few people who take Vitamin  C supplements as antioxidants. Many i have seen believe that daily supplementation works. 

Recommendations for vitamin C intake have been set by various national agencies 40 milligrams per day or 280 milligrams per week taken all at once: the United Kingdom's Food Standards Agency[1]

Vitamin C was also the first compound to ever undergo a clinical trial and was used to treat Scurvy.









  


British Journal of Pharmacology: 

Well British Journal of Pharmacology has got something new to say. They reinforced an emerging explanation for why Vitamin E , C and other antioxidants supplement disease dont prevent disease and may sometimes even cause harm. Oxygen free radicals that anti oxidant molecules neutralise are not all bad. Altough they can trigger disease they are essential for the immune defense and hormone system. Getting a surplus from supplement risk interferes with helpful free radicals. The amount of antioxidant in a healthy diet appears beneficial. 

Vitamin E too ways is proven to not have any effects on preventing heart disease and now comes along Vitamin C and other antioxidants. 

Coffee does prevent cancer unless it is too hot. 

Coffee was stripped of its possible carcinogenic classification by the International Agency for Research on Cancer. Altough any beverage warmer than 65 degree/scalding hot liquids can injure cells in esophagus contributing oesophageal cancer down the road. Coffee served at moderate temperature appears to have mild protective effects against cancer. 

Lift more, Use lighter weight for strength: 

Journal of Applied Physiology from the recently concluded Canadian study found that lifting light objects many times works just as well as lifting heavier ones fewer times. Key is to work the muscles until they are fatigued which is a sign of activated fibers. Low load high repetition training is already a method of choice. 

Happy research; There is no substitute for face to face interaction when it comes to fighting depression. Social media does not work. Adding fruits and vegetables in ones diet can make a person happy concluded the Australian study with 12,000 people. 

The sad part of Happy research is One cannot control behaviour with psychology or health placebo/remedies. Good Psychology beats Bad behavior is a myth.

If one wants to wrestle the pig it is going to get dirty. One should avoid getting dirty while wrestling the pig is a tough thing to do. 

Hang over cure: Dutch and Canadian study found that using water to cure hangover symptoms dont work. 

Multiple Sclerosis Research:

More than 100,000 people are diagnosed with MS in the UK around one-in-five are progressive. MS is caused by a rogue immune system mistaking part of the brain for a hostile invader and attacking it.

A drug that alters the immune system has been described as "big news" and a "landmark" in treating multiple sclerosis, doctors and charities say.Trials, published in the New England Journal of Medicine, suggest the drug can slow damage to the brain in two forms of MS.
'Change treatment'
Ocrelizumab is the first drug shown to work in the primary progressive form of the disease. The drug is being reviewed for use in the US and Europe. The drug is being considered by the European Medicines Agency and the US Food and Drug Administration.

Ocrelizumab kills a part of the immune system - called B cells - which are involved in the assault on the myelin sheath. In 732 patients with progressive MS, the percentage of patients that had deteriorated fell from 39% without treatment to 33% with Ocrelizumab Patients taking the drug also scored better on the time needed to walk 25 feet and had less brain loss detected on scans. In 1,656 patients with relapsing remitting, the relapse rate with ocrelizumab was half that of using another drug.


No comments:

Post a Comment